grant
Resources, Workforce Development, and Animal Models for the Rutgers RBL
Organization RUTGERS BIOMEDICAL AND HEALTH SCIENCESLocation Newark, UNITED STATESPosted 18 Aug 2023Deadline 31 Jul 2028
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoVAIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAdvanced InstrumentationAfter CareAfter-TreatmentAftercareAnimal HusbandryAnimal ModelAnimal Models and Related StudiesAnimalsAntitubercular DrugsB anthracisB. anthracisBacillus anthracisBiological AgentBiological ProductsBody TissuesBudgetsC aurisC. aurisCHIKVCOVID-19COVID-19 virusCOVID19 virusCV-19Candida aurisCategoriesCell BodyCellsCertificationChikungunya virusCoV-2CoV2CollaborationsComputer InstrumentationComputers and Advanced InstrumentationContainmentCoronavirus Infectious Disease 2019CryptococcusDevelopmentDiagnosticDiagnostics ResearchDisastersDrug TherapyEmergency responseEmerging Communicable DiseasesEmerging Infectious DiseasesEnsureEnvironmentEquipmentEquipment and supply inventoriesF tularensisF. tularensisFacultyFrancisella tularensisFundingGoalsGrantHIVHealthHuman Immunodeficiency VirusesImpairmentInfectious disease threatInfluenza VirusInstitutionInventoryInvestigatorsJointsLAV-HTLV-IIILaboratoriesLaboratory ResearchLife CycleLife Cycle StagesLymphadenopathy-Associated VirusM tbM tuberculosisM tuberculosis infectionM. tbM. tb infectionM. tuberculosisM. tuberculosis infectionM.tb infectionM.tuberculosis infectionMTB infectionMaintenanceMicrobiologyMissionModelingMonkey PoxMonkeypoxMycobacterium tuberculosisMycobacterium tuberculosis (MTB) infectionMycobacterium tuberculosis infectionNational Institutes of HealthPASCPasteurella pestisPasteurella tularensisPathogenesisPathogenicityPerformancePharmacological TreatmentPharmacotherapyPost Acute Sequelae of COVID19Post Acute Sequelae of SARS-CoV-2Post Acute Sequelae of SARS-CoV2Post Acute Sequelae of severe acute respiratory syndrome coronavirus 2Post-Acute Sequelae of SARS-CoV-2 InfectionProceduresR-Series Research ProjectsR01 MechanismR01 ProgramResearchResearch ActivityResearch ContractsResearch GrantsResearch PersonnelResearch Project GrantsResearch ProjectsResearch ResourcesResearch SupportResearch TrainingResearchersResourcesSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SafetyScientistServicesSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome related corona virus 2ShippingSystemTB drugsTB infectionTB therapyTB treatmentTherapeuticTissuesTorulaTrainingTuberculosisUnited StatesUnited States National Institutes of HealthUniversitiesViralVirulentVirus-HIVWaste ManagementWorkWorkforce DevelopmentWuhan coronavirusY pestisY. pestisYersinia pestisadverse sequelae of COVIDadverse sequelae of COVID-19adverse sequelae of coronavirus diseaseadverse sequelae of coronavirus disease 2019anthracisanti-TB drugsanti-tuberculosis drugsbio-threatbiocontainment facilitybiocontainment labbiocontainment laboratorybiologicsbiopharmaceuticalbiosecuritybiotherapeutic agentbiothreatchronic COVID-19 sequelaecoronavirus disease 2019coronavirus disease 2019 viruscoronavirus disease-19coronavirus disease-19 viruscoronavirus infectious disease-19costdevelopmentaldisease modeldisorder modeldisseminated TBdisseminated tuberculosisdrug interventiondrug treatmentend of lifeend-of-lifehCoV19improvedinfection due to Mycobacterium tuberculosisinfluenzaviruslaboratory facilitylife courselong haul sequelae of COVID-19long haul sequelae of coronavirus disease 2019long-term sequelae of COVID-19long-term sequelae of SARS-CoV-2long-term sequelae of coronavirus disease 2019long-term sequelae of severe acute respiratory syndrome coronavirus 2model of animalmpoxmtbnCoV2operationoperationspandemicpandemic diseasepandemic disease preparednesspandemic planningpandemic preparednesspandemic readinesspathogenpharmaceutical interventionpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticspost COVID-19 sequelaepost acute sequelae following COVID-19post treatmentpost-acute sequelae following SARS-CoV-2 infectionpost-acute sequelae of COVID-19post-acute sequelae of acute COVID infectionpost-acute sequelae of coronavirus disease 2019public health emergencypulmonaryrecruitresponsetreat M. tuberculosistreat Mtbtreat Mycobacterium tuberculosistreat tbtreat tuberculosistuberculosis drugstuberculosis infectiontuberculosis therapytuberculosis treatmenttuberculous spondyloarthropathyviral transmissionvirologyvirus transmission
Description preview
Overall ABSTRACT
The Rutgers University Regional Biocontainment Laboratory (RBL) serves as a central facility to perform
biosafety level three (BSL3) therapeutic, pathogenesis, and diagnostic research on high threat biological agents
with a focus on Mycobacterium tuberculosis and SARS-CoV-2, as well as other category A, B, and C pathogens.
The…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click